Atopica® (cyclosporine capsules USP) for Dogs
Target the underlying problems associated with canine atopic dermatitis rather than just chasing the symptoms. Get long lasting control with Atopica, a proven long-term solution.
Why choose Atopica?
Atopica provides long-term, well-tolerated control of atopic dermatitis with a broad mode of action that targets the source of inflammation.1, 2
ProvenProven to relieve itch and reduce skin lesions in dogs3
Long-termLong-term control with lasting results4
Important information about Atopica
Atopica for dogs is indicated for the control of clinical signs of atopic dermatitis in dogs 6 months of age and older, and greater than 2 kg body weight.5
Cyclosporine
Oral capsule
Atopica Dosing and Administration Table
| Dog body weight (kg) - 2-2.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 10 mg capsule |
| Dog body weight (kg) - 3-3.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 2 x 10 mg capsules |
| Dog body weight (kg) - 4-7.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 25 mg capsule |
| Dog body weight (kg) - 8-14.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 50 mg capsule |
| Dog body weight (kg) - 15-28.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 100 mg capsules |
| Dog body weight (kg) - 29-35.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 100 mg capsule + 50 mg capsule |
| Dog body weight (kg) - 36-55.9 kg |
| Dose 5 mg/kg
(range 3.3 – 6.7 mg/kg) - 2 x 100 mg capsules |
| Dog body weight (kg) | Dose 5 mg/kg (range 3.3 – 6.7 mg/kg) |
|---|---|
| 2-2.9 kg | 10 mg capsule |
| 3-3.9 kg | 2 x 10 mg capsules |
| 4-7.9 kg | 25 mg capsule |
| 8-14.9 kg | 50 mg capsule |
| 15-28.9 kg | 100 mg capsules |
| 29-35.9 kg | 100 mg capsule + 50 mg capsule |
| 36-55.9 kg | 2 x 100 mg capsules |
Atopica is an oral form of cyclosporine, a non-steroidal immune-modulating agent that has been helping to provide safe and effective control of the clinical signs of atopic dermatitis in dogs for over 10 years.
Get long-lasting control with Atopica®, a proven long-term solution
With continued use and as clinical signs improve; the dosing frequency of Atopica® can be lowered, reducing the need to medicate daily. Because Atopica® can help improve the overall health of the skin, this can reduce the susceptibility to secondary infections and also the costs and hassles of repeated visits for these additional issues4
Treat atopic dermatitis beyond the itch with Atopica.
Indication
Atopica for dogs is indicated for the control of clinical signs of atopic dermatitis in dogs 6 months of age and older, and greater than 2 kg body weight.5
Contraindications
ATOPICA is contraindicated for use in dogs with a history of malignancy, or with a demonstrated hypersensitivity to cyclosporine A.
Cautions
It is important to conduct a comprehensive physical and clinical examination to rule-out causes of pruritus and dermatitis unrelated to atopy, such as food allergy, parasitism and primary pyoderma, and to treat any secondary bacterial, fungal or parasitic infections before prescribing ATOPICA.
The safety and efficacy of ATOPICA has not been established in dogs less than 6 months of age or less than 2 kg body weight. Safety has not been established in breeding dogs, pregnant or lactating bitches; therefore, ATOPICA should not be used in these animals.
ATOPICA should not be used in young dogs without full adult dentition. Cyclosporine can cause gingival hyperplasia, which may interfere with tooth eruption, which may in turn affect tooth enamel. Development of gingival hyperplasia is usually associated with elevated doses or prolonged administration and is generally reversible after cessation of treatment. If signs of diabetes mellitus are observed following the use of the product, e.g. polyuria or polydipsia, the dose should be tapered or discontinued and veterinary care sought.
